BIOS Stock Ownership Activity

BIOPLUS ACQUISITION CORP-A 13F holders

No value investing guru has made any change to the BIOPLUS ACQUISITION CORP-A (BIOS) position according to the gurus' latest SEC quarterly report(s).

Which gurus or hedge funds are buying BIOS now?

According to the latest SEC filing(s) BIOPLUS ACQUISITION CORP-A (BIOS) has not been purchased by any super investor.

To see more about who is investing in BIOPLUS ACQUISITION CORP-A (BIOS), please go to the BIOS ownership page.

History
Name
Company
%
Activity
Share
Change
% change to
Portfolio
% of
Portfolio
2023 Q3 (1 result)
Howard Marks
Oaktree Capital Management
-100.00%
-100,000
-0.02%
0.00%
Current price: $10.80 1.41% Reported price*: $10.65
2022 Q1 (1 result)
Howard Marks
Oaktree Capital Management
buy
+79,000
+0.01%
0.01%
Current price: $10.80 9.31% Reported price*: $9.88
2 of 2

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.